Vident Investment Advisory, LLC Jazz Pharmaceuticals PLC Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$122.5 - $147.16 $6.2 Million - $7.45 Million	-50,653 Reduced 73.63%	18,142 $2.25 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $6.51 Million - $7.8 Million	48,595 Added 240.57%	68,795 $10.1 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $144,508 - $178,072	-1,114 Reduced 5.23%	20,200 $3.22 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $724,221 - $922,110	-5,721 Reduced 21.16%	21,314 $2.8 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $2.29 Million - $2.73 Million	-16,166 Reduced 37.42%	27,035 $4.21 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $2.04 Million - $2.53 Million	-15,729 Reduced 26.69%	43,201 $6.73 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $1.51 Million - $1.83 Million	-12,579 Reduced 17.59%	58,930 $7.51 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $7.21 Million - $10.4 Million	56,013 Added 361.47%	71,509 $9.31 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $112,780 - $131,239	-704 Reduced 4.35%	15,496 $2.75 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $239,102 - $276,212	-1,592 Reduced 8.95%	16,200 $2.66 Million
Q4 2020 Feb 08, 2021	SELL	$140.71 - $165.05 $177,153 - $207,797	-1,259 Reduced 6.61%	17,792 $2.94 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $232,433 - $317,662	-2,204 Reduced 10.37%	19,051 $2.72 Million
Q2 2020 Jul 17, 2020	SELL	$95.68 - $121.88 $569,200 - $725,064	-5,949 Reduced 21.87%	21,255 $2.35 Million
Q1 2020 May 12, 2020	BUY	$87.74 - $152.74 $2.01 Million - $3.49 Million	22,874 Added 528.27%	27,204 $2.71 Million
Q4 2019 Feb 11, 2020	SELL	$117.65 - $153.73 $15,529 - $20,292	-132 Reduced 2.96%	4,330 $646,000
Q3 2019 Nov 13, 2019	SELL	$125.18 - $143.24 $1,251 - $1,432	-10 Reduced 0.22%	4,462 $572,000
Q2 2019 Aug 12, 2019	SELL	$125.55 - $144.48 $348,275 - $400,787	-2,774 Reduced 38.28%	4,472 $638,000
Q1 2019 May 08, 2019	BUY	$121.81 - $142.95 $337,779 - $396,400	2,773 Added 61.99%	7,246 $1.04 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $518,599 - $745,828	4,473 New	4,473 $554,000
Q1 2018 May 14, 2018	SELL	$135.59 - $157.16 $3.34 Million - $3.87 Million	-24,636 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$131.06 - $150.39 $172,999 - $198,514	1,320 Added 5.66%	24,636 $3.32 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $3.33 Million - $3.63 Million	23,316	23,316 $3.41 Million

Others Institutions Holding JAZZ

# of Institutions

490

Shares Held

57M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.95B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account